AGP Executive Report
Last update: 4 hours agoSleep-Supplement Safety: A University of Connecticut mouse study found tolerance and withdrawal symptoms after three days of repeated CBN use, raising questions about long-term use of cannabis-derived sleep products. The results do not establish the same effects in people. Cannabis and Heart Health: Recent research links cannabis legalization with higher heart-related hospital admissions. The reported link warrants attention but does not prove legalization caused the increase. Pain Research: An early clinical trial found a single cannabis extract dose reduced opioid needs for some acute-pain patients; a U.S. trial of a cannabis-based pain medicine is also underway. Industry and Policy: Virginia Sen. L. Louise Lucas faces federal charges in an alleged marijuana distribution scheme and denies wrongdoing. Massachusetts voters are being asked to repeal the state’s adult-use cannabis framework. CBD Consumer Advice: A new guide urges shoppers to check CBD labels carefully and look beyond marketing claims.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
